Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Neurochemical effects of new 5-HT6 antagonist in rat medial prefrontal cortex

July 4, 2002

Behavioral effects of SSR-149415 in animal models of anxiety and depression

July 4, 2002

Melanoma vaccine candidate based on bacterial adjuvant protein and MART-1-derived peptide

July 4, 2002

New data on the use of omapatrilat in hypertension and chronic heart failure

July 4, 2002

Clinical trials confirm that eplerenone is safe and effective in Rx of hypertension

July 4, 2002

BI-K0376 effective against multiresistant acne-associated bacteria

July 4, 2002

Resiquimod prevents recurrence of genital herpes

July 3, 2002

Pretreatment with Genasense being tested for advanced malignant melanoma

July 3, 2002

In vitro evidence for efficacy of bosentan in malignant melanoma presented in Paris

July 3, 2002

New IL-4 variant evaluated for safety in phase I trial in MS patients

July 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...